EUVIMEDEUVIMED entdecken
Fallbericht

Use of tofacitinib in baricitinib‐refractory atopic dermatitis: An example of JAK inhibitor switching

Bhawuk Dhir, Sumitra Kumari Meena, Kabir Sardana iD, Savitha Sharath

Pediatric Dermatology · 2024

DOI: 10.1111/pde.15386 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Bhawuk Dhir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Research Institute and Dr Ram Manohar Lohi…. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Dermatitis, Atopic, Purines, Pyrazoles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is predominantly mediated by a T‐helper 2 immune system response. While JAK inhibitors have gained treatment approval for AD, data regarding interclass efficacy and therapeutic rationale is lacking. We report a patient with recalcitrant AD who failed baricitinib but demonstrated an excellent response to the pan‐JAK inhibitor tofacitinib.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase InhibitorsDermatitis, AtopicPurinesPyrazolesSulfonamidesPyrimidinesAzetidinesHumansPiperidinesTreatment Outcome

Stichwörter der Autor:innen

JAK inhibitorsatopic dermatitisbaricitinibswitchingtofacitinib

Substanzen

Janus Kinase InhibitorstofacitinibbaricitinibPiperidinesPurinesPyrazolesSulfonamidesPyrimidinesAzetidines

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Research Institute and Dr Ram Manohar Lohia Hospital, New Delhi, India.

ORCID-Profile: Kabir Sardana

Zitieren

APA

Dhir, B., Meena, S. K., Sardana, K., & Sharath, S. (2024). Use of tofacitinib in baricitinib‐refractory atopic dermatitis: An example of JAK inhibitor switching. Pediatric Dermatology. https://doi.org/10.1111/pde.15386

Vancouver

Dhir B, Meena SK, Sardana K, Sharath S. Use of tofacitinib in baricitinib‐refractory atopic dermatitis: An example of JAK inhibitor switching. Pediatric Dermatology. 2024. doi:10.1111/pde.15386

BibTeX
@article{Dhir2024,
  author = {Dhir, Bhawuk and Meena, Sumitra Kumari and Sardana, Kabir and Sharath, Savitha},
  title = {Use of tofacitinib in baricitinib‐refractory atopic dermatitis: An example of JAK inhibitor switching},
  journal = {Pediatric Dermatology},
  year = {2024},
  doi = {10.1111/pde.15386}
}
Kostenlos starten →